Editor's Note Various digital health companies are racing to introduce a new wave of artificial intelligence (AI) tools—often called AI agents—designed to handle labor-intensive tasks in healthcare with unprecedented speed. These specialized tools aim to manage everything from verifying insurance benefits and clarifying pre-procedure details for patients to aiding in…
Editor's Note The bipartisan Medical Supply Chain Resiliency Act would grant the president expanded authority to negotiate trade deals and modify tariffs on medical goods, according to a March 14 report from Fierce Healthcare. The bill, backed by pharmaceutical and healthcare industry groups, aims to strengthen the US medical supply…
Editor's Note Legislation introduced in the US House of Representatives seeks to expand access to anesthesia care for veterans by granting Certified Registered Nurse Anesthetists (CRNAs) full practice authority within the Veterans Health Administration (VHA). The Ensuring Veterans Timely Access to Anesthesia Care Act of 2025 is sponsored by Representatives…
Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…
Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…
Editor's Note Chief data officer (CDO) is a fast-growing C-suite role across the economy, with the notable exception of healthcare. The reasons why might be surprising: these roles have already been filled. Rather than growing, they are evolving. That’s the primary message of a March 4 report in Becker’s Hospital…
Editor's Note Multiple states seek to limit corporate influence in medicine by instituting additional checks on private equity-driven healthcare mergers, according to a March 17 report in Axios. Referencing multiple state-specific reports, the article summarizes specific efforts in Massachusetts, where a new law expands oversight of transactions; Maine, where a…
Editor's Note The widespread adoption of GLP-1 weight-loss medications like Ozempic and Wegovy could put revenue at risk across multiple service lines, according to a March 11 article in Becker’s Hospital Review. As a result, hospitals and ambulatory surgery centers (ASCs) face critical questions about how to adapt. The article…
Editor's Note In addition to the uptick in acquiring outpatient facilities since 2023, UnitedHealth Group quietly acquired or created more than 250 subsidiaries last year, expanding its already vast network of services comprising a major health insurer, physician practices, a pharmacy benefit manager, and various other healthcare ventures, STAT March…
Editor's Note A February 26 letter in JAMA Network reported a revised legal standard for medical negligence in the US, shifting from traditional reliance on customary practice toward a more patient-centered, evidence-based definition of “reasonable care.” The American Law Institute (ALI) updated its framework in 2024, retaining elements of prevailing…